F Vilela

1.1k total citations
9 papers, 16 citations indexed

About

F Vilela is a scholar working on Surgery, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, F Vilela has authored 9 papers receiving a total of 16 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Economics and Econometrics and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in F Vilela's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Neutropenia and Cancer Infections (1 paper). F Vilela is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Lipoproteins and Cardiovascular Health (4 papers) and Neutropenia and Cancer Infections (1 paper). F Vilela collaborates with scholars based in Switzerland, Sweden and Spain. F Vilela's co-authors include Guillermo Villa, Jonas Banefelt, Emil Hagström, Maria Lindh, Anna Norhammar, Margrét Leósdóttir, Maria Svensson, F.S. Mennini, Paolo Sciattella and Michele Intorcia and has published in prestigious journals such as European Heart Journal, Atherosclerosis and Value in Health.

In The Last Decade

F Vilela

7 papers receiving 16 citations

Peers

F Vilela

EE

SURGE

CCM

GHP

FP

D. Weinstein United States

Agnieszka Konopka Poland

Jayanth S. Vatson United States

Roberto Del Giudice Italy

Liudmyla Nykodymivna Prystupa Ukraine

Ben Forster Australia

Nishan K Purayil Qatar

Karen Konkel United States

F. Trias Spain

Heledd Thomas United Kingdom

D. Weinstein United States

F Vilela

4 ×0.4

EE

9 ×1.1

SURGE

2 ×1.0

CCM

0 ×0.0

GHP

0 ×0.0

FP

Citations per year, relative to F Vilela F Vilela (= 1×) peers D. Weinstein

Countries citing papers authored by F Vilela

Since Specialization

Citations

This map shows the geographic impact of F Vilela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Vilela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Vilela more than expected).

Fields of papers citing papers by F Vilela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Vilela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Vilela. The network helps show where F Vilela may publish in the future.

Co-authorship network of co-authors of F Vilela

This figure shows the co-authorship network connecting the top 25 collaborators of F Vilela. A scholar is included among the top collaborators of F Vilela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Vilela. F Vilela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Svensson, Maria, F Vilela, Margrét Leósdóttir, et al.. (2022). Effects of lipid-lowering treatment intensity and adherence on cardiovascular outcomes in patients with a recent myocardial infarction: a Swedish register-based study. Upsala Journal of Medical Sciences. 127. 6 indexed citations

2.

Hagström, Emil, et al.. (2021). Cardiovascular Event Rates After Myocardial Infarction or Ischaemic Stroke in Patients with Additional Risk Factors: A Retrospective Population-Based Cohort Study. Advances in Therapy. 38(9). 4695–4708. 4 indexed citations

3.

Hagström, Emil, et al.. (2020). PCV15 Rates of Major Cardiovascular Events in Patients with a History of Ischemic Stroke: Evidence from a Swedish Nationwide Register-Based Study. Value in Health. 23. S488–S489.

4.

Hagström, Emil, et al.. (2020). Rates of major cardiovascular events in patients with a history of myocardial infarction and additional risk factors: Evidence from a Swedish nationwide register-based study. Atherosclerosis. 315. e179–e179. 1 indexed citations

5.

Escobar, Carlos, et al.. (2020). Resource utilization and costs associated with achieved LDL-C levels in patients following a myocardial infarction treated with lipid-lowering therapies in Spain. European Heart Journal. 41(Supplement_2). 1 indexed citations

6.

Sciattella, Paolo, et al.. (2019). PCV84 REHOSPITALIZATION DUE TO SUBSEQUENT CARDIOVASCULAR EVENTS IN SECONDARY PREVENTION PATIENTS TREATED WITH LIPID LOWERING THERAPIES IN ITALY. Value in Health. 22. S557–S557.

7.

Laufs, Ulrich, et al.. (2019). PCV81 CURRENT TRENDS IN LIPID LOWERING THERAPY USE IN GERMANY. Value in Health. 22. S556–S556. 1 indexed citations

8.

Vilela, F, et al.. (2011). Persistencia en el tratamiento para la osteoporosis en pacientes posmenopáusicas en el ámbito de la Atención Primaria. 9(2). 46–53. 1 indexed citations

9.

López–Pousa, Antonio, et al.. (2008). Evaluación económica del uso de pegfilgrastim frente a filgrastim en profilaxis primaria en pacientes con cáncer de mama con riesgo de padecer neutropenia febril en España. 5(3). 71–81. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact